Work

Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.

Year: 1994

Type: article

Study design: Observational Study

Source: PubMed

Authors: M H Champème, I Bièche, K Hacène, R Lidereau

Institution: Hôpital René Huguenin

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2409597275

FWCI: 0.169

Cites:

Cited by: 20

Related to: 10